Carnegie Mellon develops innovative method to detect genetic causes of complex diseases

Computational biologists at Carnegie Mellon University have developed an analytical technique to detect the multiple genetic variations that contribute to complex disease syndromes such as diabetes, asthma and cancer, which are characterised by multiple clinical and molecular traits...

Read the whole article on

More from